ASTRAZENECA PHARMA INDIA
Back to Balance Sheet
|
ASTRAZENECA PHARMA INDIA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-42 Cr | ₹-21 Cr | ₹-21 Cr | ₹-16 Cr | ₹-15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ASTRAZENECA PHARMA INDIA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-42 Cr |
| Mar2024 | ₹-21 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-16 Cr |
| Mar2021 | ₹-15 Cr |
How is Deferred Tax Assets / Liabilities of ASTRAZENECA PHARMA INDIA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-42 Cr | Negative | |
| Mar2024 | ₹-21 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-16 Cr | Negative | |
| Mar2021 | ₹-15 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹21,249.3 Cr | 2.4% | 0.1% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,036.0 Cr | 0.8% | -4.2% | 7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,218.0 Cr | 1.1% | -0.7% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,099.0 Cr | 0% | 1.3% | 40.1% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | -0.3% | -4.1% | -8.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.4% | -4.5% | -5.2% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | 2.4% |
0.1% |
-16.3% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses